Impaired ACE2 glycosylation and protease activity in Fabry disease protects from COVID-19

J Intern Med. 2023 Aug;294(2):238-240. doi: 10.1111/joim.13672. Epub 2023 Jun 8.

Authors

Ilaria Caputo¹, Giovanni Bertoldi¹, Giulia Driussi¹, Luca Sgarabotto¹, Gianni Carraro¹, Lucia Federica Stefanelli¹, Paul A Davis², Lorenzo A Calò¹

Affiliations

¹ Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
² Department of Nutrition, University of California, Davis, California, USA.

PMID: 37227252
DOI: 10.1111/joim.13672

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Angiotensin-Converting Enzyme 2 / metabolism
COVID-19*
Fabry Disease*
Glycosylation
Humans
SARS-CoV-2

Substances

Angiotensin-Converting Enzyme 2